Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share and Trends Analysis Report by Service (Laboratory, Custom), Raw Material (Formulation Excipients, API), and Region 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The global biopharmaceuticals manufacturing consumables testing market size is expected to reach USD 1.27 billion by 2030, registering a CAGR of 12.3% from 2024 to 2030
The market is driven by the growing need for an in-depth assessment of raw materials for the successful and rapid launch of the final product. Rising awareness pertaining to internal standards as well as external regulations in the biopharmaceutical industry is also aiding the market growth. 
In the past few years, there has been a major paradigm shift from small chemical molecules to large biological molecules. As a result, the biopharmaceutical industry is geared toward exploring every aspect involved in the manufacturing process.
Regulatory and quality expectations for best quality raw materials and intermediates continue to increase. This, in turn, has pressurized vendors engaged in the manufacturing of excipients and raw materials to invest in standardizing functionality as well as establishing sophisticated processes to consistently address the needs of final product developers.
Biopharmaceuticals Manufacturing Consumables Testing Market Report Highlights
- Based on service, compendial and multi-compendial testing held the largest share owing to demand from various manufacturers for raw materials that are compliant to regulatory standards
- Testing services for Active Pharmaceutical Ingredients (APIs) accounted for the largest revenue share owing to the presence of a wide range of services in this segment
- Presence of a large number of biologics manufacturing entities in the U.S. has resulted in North America dominating the global market in 2023. Rising competitive rivalry amongst market participants is also attributive for the large share of this region
- Asia Pacific is expected to emerge as the fastest-growing regional market, fueled primarily by expansion of the contract service industry in several Asian countries. This is partly attributed to low operating costs in these nations
The leading players in the Biopharmaceuticals Manufacturing Consumables Testing market include:
- Alcami Corporation
- Merck KGaA
- Eurofins Scientific
- Agilent Technologies, Inc.
- Charles River Laboratories.
- Catalent, Inc
- Element Materials Technology (Avomeen Analytical Services)
- Pace Analytical Services, LLC
- Nelson Laboratories, LLC (Gibraltar Laboratories)
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 100 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $572 Million |
| Forecasted Market Value (USD) by 2030 | $1270 Million |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biopharmaceuticals Manufacturing Consumables Testing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Biopharmaceuticals Manufacturing Consumables Testing Market Analysis Tools
3.4.1. Porter's Analysis
3.4.2. PESTEL Analysis
Chapter 4. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Movement Analysis, USD Million, 2023 & 2030
4.3. Laboratory Testing
4.3.1. Laboratory Testing Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Custom Testing / Customer Proprietary Testing
4.5. Compendial & Multi Compendial Laboratory Testing
Chapter 5. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Movement Analysis, USD Million, 2023 & 2030
5.3. Formulation Excipients
5.3.1. Formulation Excipients Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
5.4. Active Pharmaceutical Ingredients (API)
5.5. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support
Chapter 6. Biopharmaceuticals Manufacturing Consumables Testing Market: Regional Estimates & Trend Analysis
6.1. Biopharmaceuticals Manufacturing Consumables Testing Market Share, By Region, 2023 & 2030, USD Million
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Participant's Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Recent Developments/ Strategic Initiatives
For more information about this report visit https://www.researchandmarkets.com/r/oz9bbj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
